Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Keluoxin Capsule for Early Diabetic Nephropathy
ChiCTR2100052764Phase 4Completed
- Sponsor
- Beijing University of Chinese Medicine
- Start
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in diabetic glomerulosclerosis comparing Keluoxin Capsule with Control: Placebo (2 arms). Primary endpoint: urinary albumin/creatinine ratio. Started Jun 2014; status: completed.
02
Drugs
Keluoxin
03
Conditions
diabetic glomerulosclerosis
Beyond the preview
Go deeper on ChiCTR2100052764.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100052764.